Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Vaxcyte, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 198 | 2 | 188 | −8 |
| Shares | 81.6M | 2.03M | 84.1M | +4.56M (+5.7%) |
| Value | $3.91B | $97.2M | $3.15B | −$661.1M (−17.3%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Vaxcyte, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Carlyle Group Inc. | 1,923,158 | $72.1M | 2.15% |
| Eagle Asset Management Inc | 227,693 | $8.53M | 0.05% |
| Sphera Funds Management Ltd. | 90,000 | $3.37M | 0.73% |
| Tudor Investment Corp Et Al | 37,861 | $1.42M | 0.03% |
| Profund Advisors LLC | 34,086 | $1.28M | 0.08% |
| Man Group plc | – | $955.4K | 0.00% |
| Guggenheim Capital LLC | 24,389 | $914.1K | 0.01% |
| Artia Global Partners LP | 22,759 | $853.0K | 0.34% |
| Algert Global LLC | 21,837 | $818.5K | 0.04% |
| HRT Financial LP | 21,688 | $812.0K | 0.01% |
| Candriam Luxembourg S.C.A. | 12,070 | $416.4K | 0.00% |
| XTX Topco Ltd | 9,729 | $364.6K | 0.08% |
| Chicago Partners Investment Group LLC | 7,159 | $310.6K | 0.02% |
| UBS Oconnor LLC | 8,071 | $302.5K | 0.01% |
| Raymond James & Associates | 7,600 | $284.8K | 0.00% |
| Fox Run Management, L.L.C. | 6,768 | $253.7K | 0.08% |
| Cutler Group LP | 3,000 | $112.0K | 0.02% |
| Russell Investments Group, Ltd. | 805 | $30.2K | 0.00% |
| Point72 Middle East FZE | 694 | $26.0K | 0.00% |
| Belpointe Asset Management LLC | 148 | $5.55K | 0.00% |
| Washington Trust Advisors, Inc. | 32 | $1.20K | 0.00% |
| Bell Investment Advisors, Inc | 13 | $488 | 0.00% |
| Institutional & Family Asset Management, LLC | 8 | $300 | 0.00% |
Sold out (31)
Institutions that held Vaxcyte, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (2)
Institutions that held Vaxcyte, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Abingworth LLP | 2,019,057 | $96.8M |
| Alpha Paradigm Partners, LLC | 7,665 | $368.0K |